Skip to Content

Benznidazole Approval History

FDA Approved: Yes (First approved August 29, 2017)
Generic name: benznidazole
Dosage form: Tablets
Company: Chemo Research, S. L.
Treatment for: Trypanosomiasis

Benznidazole is an antiprotozoal indicated for the treatment of Chagas disease, or American trypanosomiasis, a parasitic infection caused by Trypanosoma cruzi.

Development History and FDA Approval Process for benznidazole

DateArticle
Aug 29, 2017Approval FDA Approves Benznidazole as First U.S. Treatment for Chagas Disease
Jun 27, 2017Benznidazole IND for Chagas Disease Receives Clearance by FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide